JOTEC GmbH
Developer and manufacturer of aortic and cardiac implantable devices, human allografts, decellularized biomaterials, and surgical adhesives. Operates multi-site manufacturing and quality systems, manages clinical investigations and regulatory submissions (including IDE/HDE support), and provides clinician education through wet labs, cadaver simulation, video libraries, and virtual-reality training.
Industries
N/A
Nr. of Employees
small (1-50)
JOTEC GmbH
JOTEC GmbH, Lotzenäcker 23, D-72379 Hechingen, Germany
Patents
Products
Hybrid aortic arch prosthesis
A hybrid prosthesis intended to assist aortic arch remodeling and management of acute type A dissections during open surgical repair.
Mechanical heart valve systems
Mechanical valve devices intended for surgical aortic and mitral valve replacement procedures.
Cryopreserved cardiac and vascular allografts
Cryopreserved human heart valves and vascular allografts for cardiac and vascular reconstruction procedures.
Aortic arch stent graft systems (standard and custom)
Stent graft systems designed for total endovascular aortic arch repair available in off-the-shelf and custom-made configurations.
Multibranch stent graft platforms for aneurysm repair
Modular and multibranch stent graft systems intended for repair of abdominal and thoracoabdominal aneurysms.
Surgical adhesive (tissue sealant)
Surgical adhesive formulation supplied for use as an adjunct in tissue sealing and reinforcement during cardiovascular procedures.
Hybrid aortic arch prosthesis
A hybrid prosthesis intended to assist aortic arch remodeling and management of acute type A dissections during open surgical repair.
Mechanical heart valve systems
Mechanical valve devices intended for surgical aortic and mitral valve replacement procedures.
Cryopreserved cardiac and vascular allografts
Cryopreserved human heart valves and vascular allografts for cardiac and vascular reconstruction procedures.
Aortic arch stent graft systems (standard and custom)
Stent graft systems designed for total endovascular aortic arch repair available in off-the-shelf and custom-made configurations.
Multibranch stent graft platforms for aneurysm repair
Modular and multibranch stent graft systems intended for repair of abdominal and thoracoabdominal aneurysms.
Surgical adhesive (tissue sealant)
Surgical adhesive formulation supplied for use as an adjunct in tissue sealing and reinforcement during cardiovascular procedures.
Services
Didactic courses, mentored wet labs, VR and video training, and live-case observation focused on aortic, valve, and endovascular procedures.
Provision, shipment, and on-site setup/breakdown of wet-lab supplies and implantable devices for institutional training courses.
Didactic courses, mentored wet labs, VR and video training, and live-case observation focused on aortic, valve, and endovascular procedures.
Provision, shipment, and on-site setup/breakdown of wet-lab supplies and implantable devices for institutional training courses.
Expertise Areas
- Aortic and endovascular device development
- Cardiac valve design and surgical implants
- Cryopreserved allograft processing and distribution
- Decellularized biomaterials for surgical repair
Key Technologies
- Endovascular stent graft platforms
- Hybrid aortic prosthesis technology
- Mechanical heart valve systems
- Tissue cryopreservation
News & Updates
The FDA granted a Humanitarian Device Exemption for a hybrid aortic prosthesis for use in specific acute aortic dissection indications involving malperfusion.
Presentation of one-year clinical outcomes from a pivotal IDE clinical trial cohort at a professional society meeting.
Initiation and completion of enrollment milestones documented for a prospective multi-center study evaluating a hybrid prosthesis in acute aortic dissection.
Presentation of real-world safety and efficacy data from a post-market study of a mechanical aortic valve at a European cardiothoracic meeting.
Scheduled participation including lunch symposia, podium presentations, booth activities, and clinical data presentations at the EACTS 2025 conference in Copenhagen.
The FDA granted a Humanitarian Device Exemption for a hybrid aortic prosthesis for use in specific acute aortic dissection indications involving malperfusion.
Presentation of one-year clinical outcomes from a pivotal IDE clinical trial cohort at a professional society meeting.
Initiation and completion of enrollment milestones documented for a prospective multi-center study evaluating a hybrid prosthesis in acute aortic dissection.
Presentation of real-world safety and efficacy data from a post-market study of a mechanical aortic valve at a European cardiothoracic meeting.
Scheduled participation including lunch symposia, podium presentations, booth activities, and clinical data presentations at the EACTS 2025 conference in Copenhagen.